SEC Form 4 · accession 0001209191-17-040688
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Froimson
Director
Period of report
Jun 14, 2017
Accepted (ET)
Jun 16, 2017 · 8:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $44.20 | Jun 14, 2017 | A | 8,144 | A | — | Jun 14, 2027 | Common Stock | 8,144 | 8,144 | D |
Explanation of responses
- F1The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director.